Literature DB >> 20417340

Acute mountain sickness: pathophysiology, prevention, and treatment.

Chris Imray1, Alex Wright, Andrew Subudhi, Robert Roach.   

Abstract

Barometric pressure falls with increasing altitude and consequently there is a reduction in the partial pressure of oxygen resulting in a hypoxic challenge to any individual ascending to altitude. A spectrum of high altitude illnesses can occur when the hypoxic stress outstrips the subject's ability to acclimatize. Acute altitude-related problems consist of the common syndrome of acute mountain sickness, which is relatively benign and usually self-limiting, and the rarer, more serious syndromes of high-altitude cerebral edema and high-altitude pulmonary edema. A common feature of acute altitude illness is rapid ascent by otherwise fit individuals to altitudes above 3000 m without sufficient time to acclimatize. The susceptibility of an individual to high-altitude syndromes is variable but generally reproducible. Prevention of altitude-related illness by slow ascent is the best approach, but this is not always practical. The immediate management of serious illness requires oxygen (if available) and descent of more than 300 m as soon as possible. In this article, we describe the setting and clinical features of acute mountain sickness and high-altitude cerebral edema, including an overview of the known pathophysiology, and explain contemporary practices for both prevention and treatment exploring the comprehensive evidence base for the various interventions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20417340     DOI: 10.1016/j.pcad.2010.02.003

Source DB:  PubMed          Journal:  Prog Cardiovasc Dis        ISSN: 0033-0620            Impact factor:   8.194


  64 in total

1.  Diagnosis and prediction of the occurrence of acute mountain sickness measuring oxygen saturation--independent of absolute altitude?

Authors:  Veronika Leichtfried; Daniel Basic; Martin Burtscher; Raffaella Matteucci Gothe; Uwe Siebert; Wolfgang Schobersberger
Journal:  Sleep Breath       Date:  2015-06-02       Impact factor: 2.816

2.  Acute high-altitude illness: a clinically orientated review.

Authors:  Tom Smedley; Michael Pw Grocott
Journal:  Br J Pain       Date:  2013-05

Review 3.  The treatment of central sleep apnea syndromes in adults: practice parameters with an evidence-based literature review and meta-analyses.

Authors:  R Nisha Aurora; Susmita Chowdhuri; Kannan Ramar; Sabin R Bista; Kenneth R Casey; Carin I Lamm; David A Kristo; Jorge M Mallea; James A Rowley; Rochelle S Zak; Sharon L Tracy
Journal:  Sleep       Date:  2012-01-01       Impact factor: 5.849

4.  Bioavailability, tissue distribution, and excretion characteristics of the novel carbonic anhydrase inhibitor tolsultazolamide in rats.

Authors:  Jin-da Wang; Yong-ping Shi; Jing Yin; Zhi-yuan Pan; Wen-yu Cui; Yan-fang Zhang; Hai Wang
Journal:  Acta Pharmacol Sin       Date:  2013-12-16       Impact factor: 6.150

5.  Effects of low-dose acetazolamide on exercise performance in simulated altitude.

Authors:  Ernst Elisabeth; Gatterer Hannes; Burtscher Johannes; Faulhaber Martin; Pocecco Elena; Burtscher Martin
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2017-04-15

Review 6.  Interventions for preventing high altitude illness: Part 1. Commonly-used classes of drugs.

Authors:  Víctor H Nieto Estrada; Daniel Molano Franco; Roger David Medina; Alejandro G Gonzalez Garay; Arturo J Martí-Carvajal; Ingrid Arevalo-Rodriguez
Journal:  Cochrane Database Syst Rev       Date:  2017-06-27

7.  Interventions for preventing high altitude illness: Part 3. Miscellaneous and non-pharmacological interventions.

Authors:  Daniel Molano Franco; Víctor H Nieto Estrada; Alejandro G Gonzalez Garay; Arturo J Martí-Carvajal; Ingrid Arevalo-Rodriguez
Journal:  Cochrane Database Syst Rev       Date:  2019-04-23

Review 8.  Wilderness medicine.

Authors:  Douglas G Sward; Brad L Bennett
Journal:  World J Emerg Med       Date:  2014

Review 9.  Sherpas, Coca Leaves, and Planes: High Altitude and Airplane Headache Review with a Case of Post-LASIK Myopic Shift.

Authors:  Shivang G Joshi; Laszlo L Mechtler
Journal:  Curr Neurol Neurosci Rep       Date:  2019-11-28       Impact factor: 5.081

10.  Nrf2 activation: a potential strategy for the prevention of acute mountain sickness.

Authors:  Christina Lisk; Joe McCord; Swapan Bose; Tim Sullivan; Zoe Loomis; Eva Nozik-Grayck; Thies Schroeder; Karyn Hamilton; David C Irwin
Journal:  Free Radic Biol Med       Date:  2013-05-27       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.